CD4 and infection: Although the rate of individuals with detectable SARS-CoV-2-specific CD4+ T cells were significantly lower in the cancer group than the health control at day 180, the fraction of SARS-CoV-2-specific CD4+ T cells were still higher than people who had no SARS-CoV-2 vaccination or infection history.